← Back to headlines
Merck Stock Surges 19% as Investors Eye Potential $200 Milestone
Shares of pharmaceutical giant Merck have climbed significantly over the past month, prompting market analysts to evaluate the catalysts and financial metrics required for the stock to reach the $200 threshold.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Housing Crisis Surpasses Addiction as Top Reason for Irish Charity Support Requests
2h ago
Pakistan to Honor Nurse Who Rescued Sole Newborn From Hospital Fire
10h ago
Arrowhead Reports Positive Phase 3 Data for Plozasiran in Hypertriglyceridemia Trial
15h ago
Dutch Health Agency Warns of Lethal Trump-Shaped Ecstasy Pills
16h ago